PT Kimia Farma (Persero) Tbk (KAEF.JK)
IDR 600.0
(-0.83%)
IDR 600.0
(-0.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -358.42 Billion | 131.28 Billion | -223.92 Billion | 1018.97 Billion | -1853.83 Billion | 195.74 Billion |
| Net Income | -1466.12 Billion | -94.32 Billion | 302.27 Billion | 17.63 Billion | -12.72 Billion | 415.89 Billion |
| Depreciation & Amortization | 693.43 Billion | 225.61 Billion | 391.77 Billion | 244.35 Billion | 159.65 Billion | 178.51 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 1801.13 Billion | -131.28 Billion | -917.97 Billion | 756.97 Billion | -2000.76 Billion | -415.89 Billion |
| Investing Cash Flow | -728.65 Billion | -119.41 Billion | -648.45 Billion | -539.95 Billion | -2124.68 Billion | -1130.03 Billion |
| Investments in PPE | -744.7 Billion | -596.61 Billion | -659.25 Billion | -548.57 Billion | -778.86 Billion | -1051.05 Billion |
| Acquisitions | 16.04 Billion | 460 Billion | 2.12 Billion | 1.13 Billion | -1361 Billion | -309.12 Billion |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1000.00 | 17.19 Billion | 8.67 Billion | 7.49 Billion | 15.18 Billion | -78.97 Billion |
| Financing Cash Flow | -272.02 Billion | 1462.7 Billion | 364.35 Billion | -590.16 Billion | 3275.1 Billion | 1842.18 Billion |
| Debt repayment | -118.21 Billion | -15141.85 Billion | -868.69 Billion | -8769.92 Billion | -11163.99 Billion | -2500.11 Billion |
| Dividends payments | - | -9.02 Billion | -702.22 Million | - | -83.19 Billion | -98.08 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 254.64 Billion | - | - | - |
| Other Financing Activities | -153.81 Billion | 16613.59 Billion | -503.64 Billion | 8179.76 Billion | 14522.29 Billion | 1940.26 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 2191.07 Billion | 748.48 Billion | 1249.99 Billion | 1360.26 Billion | 2068.66 Billion | 989.63 Billion |
| Cash at end of period | 832.67 Billion | 2153.02 Billion | 748.48 Billion | 1249.99 Billion | 1360.26 Billion | 1960.03 Billion |
| Capital Expenditure | -744.7 Billion | -596.61 Billion | -659.25 Billion | -548.57 Billion | -778.86 Billion | -1051.05 Billion |
| Effect of forex changes on cash | 700.72 Million | 9.5 Billion | 6.51 Billion | 872.1 Million | -4.98 Billion | 288.45 Million |
| Net cash flow / Change in cash | -1358.4 Billion | 1404.54 Billion | -501.51 Billion | -110.27 Billion | -708.39 Billion | 970.4 Billion |
| Free Cash Flow | -1103.12 Billion | -465.32 Billion | -883.17 Billion | 470.4 Billion | -2632.7 Billion | -855.31 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -195.05 Billion | -124.04 Billion | -102.73 Billion | -1466.12 Billion | -1288.76 Billion | -137.02 Billion |
| Depreciation & Amortization | 133.15 Billion | 146.56 Billion | 146.33 Billion | 693.43 Billion | 272.52 Billion | 149.85 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | -6.87 Billion | 217.54 Billion | 260.44 Billion | 1801.13 Billion | 2259.63 Billion | -190.97 Billion |
| Investing Cash Flow | -76.12 Billion | 162.4 Billion | -58.94 Billion | -728.65 Billion | -274.72 Billion | -190.55 Billion |
| Investments in PPE | -75.75 Billion | -69.04 Billion | -58.94 Billion | -744.7 Billion | -290.48 Billion | -193.64 Billion |
| Acquisitions | - | - | - | 16.04 Billion | 15.75 Billion | -32.29 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 229 Billion | - | - | - | - |
| Other Investing Activities | - | 231.01 Billion | -185.03 Million | -1000.00 | 96.59 Billion | 3.12 Billion |
| Financing Cash Flow | 107.48 Billion | 126.61 Billion | -476.02 Billion | -272.02 Billion | -422.41 Billion | 327.58 Billion |
| Debt repayment | -93.37 Billion | -93.97 Billion | -438.33 Billion | -118.21 Billion | -12.22 Billion | -2116.89 Billion |
| Dividends payments | -30.54 Million | -33.89 Million | -9.78 Million | - | -6.63 Billion | -5.37 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 200.89 Billion | 35.34 Billion | -35.34 Billion | -153.81 Billion | -441.26 Billion | 2449.85 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 542.5 Billion | 309.05 Billion | 832.67 Billion | 2191.07 Billion | 792.72 Billion | 833.78 Billion |
| Cash at end of period | 505.1 Billion | 542.5 Billion | 309.05 Billion | 832.67 Billion | 832.67 Billion | 792.72 Billion |
| Capital Expenditure | -75.75 Billion | -69.04 Billion | -58.94 Billion | -744.7 Billion | -290.48 Billion | -193.64 Billion |
| Effect of forex changes on cash | - | -51.64 Million | -17.6 Million | 700.72 Million | 684 Million | 38.94 Million |
| Net cash flow / Change in cash | -37.39 Billion | 233.44 Billion | -523.61 Billion | -1358.4 Billion | 39.95 Billion | -41.06 Billion |
| Free Cash Flow | -144.52 Billion | -122.11 Billion | -47.57 Billion | -1103.12 Billion | 407.87 Billion | -371.78 Billion |
0288
CANDOUR
OMIC
NBTX
GABI
GANGESSECU